The National Times - Guinness maker Diageo cuts outlook on weak US, China demand

Guinness maker Diageo cuts outlook on weak US, China demand


Guinness maker Diageo cuts outlook on weak US, China demand
Guinness maker Diageo cuts outlook on weak US, China demand / Photo: © AFP/File

Diageo, the maker of Guinness stout and Smirnoff vodka, cut its sales outlook and slashed shareholder payouts Wednesday, as its new chief executive seeks to revive the struggling drinks group.

Change text size:

The British company said it expects full-year net sales to fall two to three percent in its fiscal year ending on June 30, citing weakness in the United States and China.

"Only several weeks in, I can already see significant opportunities for Diageo to act more decisively to enhance its competitiveness," chief executive Dave Lewis said in an earnings statement

Lewis, a former chief executive of British supermarket giant Tesco who has a reputation for cost-cutting, took the helm in January following the sudden departure of Debra Crew.

Net sales fell four percent to $10.5 billion in the six months to December, compared with one year earlier, Diageo said.

Net profit, meanwhile, rose 3.1 percent to almost $2 billion in its first half.

In an earnings presentation, Lewis said pressure on customer wallets was "by far and away" the biggest economic challenge for the company.

The group said it is facing mounting competition from cheaper brands in the United States, particularly in tequila, as consumers confront cost-of-living pressures.

Diageo announced it is more than halving its first-half dividend, sending shares down around eight percent on London's benchmark FTSE 100 index, which was trading higher overall.

The company, which makes Johnnie Walker whisky, Baileys liqueur and Don Julio tequila, said it is ramping up its cost-savings programme.

Diageo has sought to reduce its debt amid a tough trading environment and after announcing in May that it faces a financial hit from US President Donald Trump's tariffs onslaught.

At the end of last year, the company gave a profit warning as it cautioned over weaker consumer demand in China and the United States.

"The business is not doing as well in the once lucrative North American market and China is not lining its pockets with riches either," said Dan Coatsworth, head of markets at AJ Bell.

"There is no point trying to dress up the six-month figures. These are awful results, and the repair job is massive," he added.

W.Phillips--TNT

Featured

Carney touts Canada 'pivot' away from US as tariffs rise

Canadian Prime Minister Mark Carney on Tuesday said reducing economic ties with the United States would come at a cost but the long-term benefits were clear, as retaliatory tariffs on US products took effect.

The "Everlasting Battery" Inside Your Joints:UConn Professor's Self-Powered Healing Material just Got Acquired

A material that turns your own movement into medicine has just landed a corporate home. PetVivo Holdings (OTCQX: PETV), a veterinary biotech and biomedical device company focused on treating osteoarthritis in dogs and horses, has acquired PiezoBioMembrane (PBM) — a startup built around a biodegradable implant that generates electricity from the everyday force of a joint in motion, and uses that charge to help regrow cartilage from the inside out. The material is the invention of Thanh Nguyen, a professor of mechanical engineering in UConn's College of Engineering, who founded PBM in 2021 to advance new implementation methods for his work with piezoelectric materials — substances that convert mechanical force into electrical energy. These materials are typically ceramics: hard, brittle, and poorly suited for medical use. But Nguyen's lab developed new forms that are so , flexible, and biodegradable, breaking down naturally within the body over time. wound healing, The materials have already shown strong potential across a range of medical applications, including tissue regeneration, implanted force sensors, and targeted drug delivery in tumor treatment. How It Works biodegradable ultrasound for In the case of arthritis, Nguyen explains, the piezoelectric materials function as an off-the-shelf product that can be implanted or injected directly into the ailing joint — with no drugs, chemicals, or cells required. The everyday force exerted on the joint generates a small electrical charge, which helps regrow healthy cartilage, mimicking the body's natural use of electricity to regenerate tissue. "The body can be electrically stimulated to regrow," Nguyen says. PBM's materials "act like a battery — an everlasting battery that works whenever there is a force applied, and vanishes safely inside the body over time." PetVivo's Vision for the Acquisition PetVivo Holdings CEO John Lai expressed enthusiasm for the merger's potential to improve the lives of companion animals globally. "PBM has developed a compelling functional biomaterials platform with the potential to support the development of multiple medical device and therapeutic product lines across both human and animal health markets," Lai said in a press release. "By combining PBM's scientific innovation with PetVivo's product development capabilities, commercialization experience, regulatory expertise, and public company infrastructure, we believe we can accelerate theadvancement of technologies that may serve as the foundation for numerous future products and strategic opportunities." For Nguyen, the deal is a chance to scale technology that could eventually benefit both animals and people. "PetVivo is an animal health company, but they do have a big passion: pushing the technology towards clinical trials for human use," Nguyen says. "That aligned perfectly with my passion for developing technology that has an impact on human life. That is why I am excited about this merger, which facilitates my passion." A Track Record of Innovation Nguyen's research sits at the intersection of medicine, micro/nanotechnology, and biomaterials. His inventions have earned him publications in prominent scientific journals and media coverage from outlets including NPR. Nguyen founded PBM during the COVID-19 pandemic, a er realizing the material he had developed could be used to create an especially effective, biodegradable face mask — one where the mechanical force of breathing generated an electrical charge that provided an extra layer of protection against viruses. PBM is not Nguyen's only venture in the acquisition pipeline. His other startup, Single-Time Microneedles (STM), is also currently undergoing an acquisition process. STM has pioneered stable, efficient vaccine delivery technology in the form of an adhesive patch. shelfNguyen's focus on biodegradable materials has translated into a remarkably diverse range of medical applications. He has received five R01 grants from the National Institutes of Health (NIH) supporting research in cartilage regeneration, bone regeneration, HIV antibody delivery systems, and biodegradable ultrasound technology to boost the effectiveness of chemotherapy for brain cancer. "Whatever we are working on, we want to show that it works very well in vitro and in vivo," Nguyen says. "Then, when we are at the point of commercialization, we set up a startup or license the technology — or maybe team up with an industry partner." Thanh Nguyen is a professor of mechanical engineering in UConn's College of Engineering. (Courtesy of Thanh Nguyen

Octrado introduces its proprietary trading offering: "Your Skill. Our Capital"

Infrastructure, transparent rules and clear legal boundaries positioned as the core of the funded-account model

Could gas prices return to 2022 highs on US-Iran war?

European gas prices have more than doubled owing to the US-Iran war, just as Europe needs to replenish its reserves ahead of winter.

Change text size: